(19)
(11) EP 1 309 551 A1

(12)

(43) Date of publication:
14.05.2003 Bulletin 2003/20

(21) Application number: 01976067.7

(22) Date of filing: 09.08.2001
(51) International Patent Classification (IPC)7C07D 209/08, C07D 401/12, C07D 403/12, C07D 403/14, C07D 413/12, C07D 417/12, C07D 493/10, A61K 31/4453, A61K 31/496, A61K 31/5377
// (C07D493/10, 317:00), C07D221:00,(C07D493/10, 319:00), C07D221:00
(86) International application number:
PCT/EP0109/273
(87) International publication number:
WO 0201/4273 (21.02.2002 Gazette 2002/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.08.2000 GB 0019950

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford,Middlesex TW8 9GS (GB)

(72) Inventors:
  • BROMIDGE, Steven, MarkGlaxoSmithKline Pharm.
    Harlow,Essex CM19 5AW (GB)
  • LOVELL, Peter, JohnGlaxoSmithKline Pharm.
    Harlow,Essex CM19 5AW (GB)
  • MOSS, Stephen, FrederickGlaxoSmithKline Pharm.
    Harlow,Essex CM19 5AW (GB)
  • SERAFINOWSKA, Halina,TeresaGlaxoSmithKline Pharm.
    Harlo w,Essex CM19 5AW (GB)

(74) Representative: Kondo, Rie 
GlaxoSmithKline,CIP,CN925.1,980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS